BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

381 related articles for article (PubMed ID: 27760204)

  • 21. beta-Adrenoreceptors reactivate Kaposi's sarcoma-associated herpesvirus lytic replication via PKA-dependent control of viral RTA.
    Chang M; Brown HJ; Collado-Hidalgo A; Arevalo JM; Galic Z; Symensma TL; Tanaka L; Deng H; Zack JA; Sun R; Cole SW
    J Virol; 2005 Nov; 79(21):13538-47. PubMed ID: 16227274
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Kaposi's sarcoma-associated herpesvirus-encoded LANA interacts with host KAP1 to facilitate establishment of viral latency.
    Sun R; Liang D; Gao Y; Lan K
    J Virol; 2014 Jul; 88(13):7331-44. PubMed ID: 24741090
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Kruppel-associated box domain-associated protein-1 as a latency regulator for Kaposi's sarcoma-associated herpesvirus and its modulation by the viral protein kinase.
    Chang PC; Fitzgerald LD; Van Geelen A; Izumiya Y; Ellison TJ; Wang DH; Ann DK; Luciw PA; Kung HJ
    Cancer Res; 2009 Jul; 69(14):5681-9. PubMed ID: 19584288
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of Notch signal transduction in Kaposi's sarcoma-associated herpesvirus gene expression.
    Chang H; Dittmer DP; Shin YC; Hong Y; Jung JU
    J Virol; 2005 Nov; 79(22):14371-82. PubMed ID: 16254371
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Concurrent expression of latent and a limited number of lytic genes with immune modulation and antiapoptotic function by Kaposi's sarcoma-associated herpesvirus early during infection of primary endothelial and fibroblast cells and subsequent decline of lytic gene expression.
    Krishnan HH; Naranatt PP; Smith MS; Zeng L; Bloomer C; Chandran B
    J Virol; 2004 Apr; 78(7):3601-20. PubMed ID: 15016882
    [TBL] [Abstract][Full Text] [Related]  

  • 26. STAT3 Regulates Lytic Activation of Kaposi's Sarcoma-Associated Herpesvirus.
    King CA; Li X; Barbachano-Guerrero A; Bhaduri-McIntosh S
    J Virol; 2015 Nov; 89(22):11347-55. PubMed ID: 26339061
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human immunodeficiency virus type-1 activates lytic cycle replication of Kaposi's sarcoma-associated herpesvirus through induction of KSHV Rta.
    Varthakavi V; Smith RM; Deng H; Sun R; Spearman P
    Virology; 2002 Jun; 297(2):270-80. PubMed ID: 12083825
    [TBL] [Abstract][Full Text] [Related]  

  • 28. X box binding protein XBP-1s transactivates the Kaposi's sarcoma-associated herpesvirus (KSHV) ORF50 promoter, linking plasma cell differentiation to KSHV reactivation from latency.
    Wilson SJ; Tsao EH; Webb BL; Ye H; Dalton-Griffin L; Tsantoulas C; Gale CV; Du MQ; Whitehouse A; Kellam P
    J Virol; 2007 Dec; 81(24):13578-86. PubMed ID: 17928342
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Convergence of Kaposi's sarcoma-associated herpesvirus reactivation with Epstein-Barr virus latency and cellular growth mediated by the notch signaling pathway in coinfected cells.
    Spadavecchia S; Gonzalez-Lopez O; Carroll KD; Palmeri D; Lukac DM
    J Virol; 2010 Oct; 84(20):10488-500. PubMed ID: 20686042
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The cellular peptidyl-prolyl cis/trans isomerase Pin1 regulates reactivation of Kaposi's sarcoma-associated herpesvirus from latency.
    Guito J; Gavina A; Palmeri D; Lukac DM
    J Virol; 2014 Jan; 88(1):547-58. PubMed ID: 24173213
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activation of the Kaposi's sarcoma-associated herpesvirus major latency locus by the lytic switch protein RTA (ORF50).
    Matsumura S; Fujita Y; Gomez E; Tanese N; Wilson AC
    J Virol; 2005 Jul; 79(13):8493-505. PubMed ID: 15956592
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Early activation of the Kaposi's sarcoma-associated herpesvirus RTA, RAP, and MTA promoters by the tetradecanoyl phorbol acetate-induced AP1 pathway.
    Wang SE; Wu FY; Chen H; Shamay M; Zheng Q; Hayward GS
    J Virol; 2004 Apr; 78(8):4248-67. PubMed ID: 15047839
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Kaposi's sarcoma-associated herpesvirus RTA activates the processivity factor ORF59 through interaction with RBP-Jkappa and a cis-acting RTA responsive element.
    Liu Y; Cao Y; Liang D; Gao Y; Xia T; Robertson ES; Lan K
    Virology; 2008 Oct; 380(2):264-75. PubMed ID: 18786687
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Notch signal transduction induces a novel profile of Kaposi's sarcoma-associated herpesvirus gene expression.
    Chang H
    J Microbiol; 2006 Apr; 44(2):217-25. PubMed ID: 16728959
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Kaposi's sarcoma-associated herpesvirus transactivator RTA promotes degradation of the repressors to regulate viral lytic replication.
    Yang Z; Yan Z; Wood C
    J Virol; 2008 Apr; 82(7):3590-603. PubMed ID: 18216089
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The transcriptional repressor K-RBP modulates RTA-mediated transactivation and lytic replication of Kaposi's sarcoma-associated herpesvirus.
    Yang Z; Wood C
    J Virol; 2007 Jun; 81(12):6294-306. PubMed ID: 17409159
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chromatin remodeling controls Kaposi's sarcoma-associated herpesvirus reactivation from latency.
    Hopcraft SE; Pattenden SG; James LI; Frye S; Dittmer DP; Damania B
    PLoS Pathog; 2018 Sep; 14(9):e1007267. PubMed ID: 30212584
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Resveratrol inhibits KSHV reactivation by lowering the levels of cellular EGR-1.
    Dyson OF; Walker LR; Whitehouse A; Cook PP; Akula SM
    PLoS One; 2012; 7(3):e33364. PubMed ID: 22428032
    [TBL] [Abstract][Full Text] [Related]  

  • 39. KSHV lytic proteins K-RTA and K8 bind to cellular and viral chromatin to modulate gene expression.
    Kaul R; Purushothaman P; Uppal T; Verma SC
    PLoS One; 2019; 14(4):e0215394. PubMed ID: 30998737
    [TBL] [Abstract][Full Text] [Related]  

  • 40. FoxO1 Suppresses Kaposi's Sarcoma-Associated Herpesvirus Lytic Replication and Controls Viral Latency.
    Gao R; Li T; Tan B; Ramos da Silva S; Jung JU; Feng P; Gao SJ
    J Virol; 2019 Feb; 93(3):. PubMed ID: 30404794
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.